Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Immunocore Holdings ( (IMCR) ).
On November 26, 2025, Ranjeev Krishana resigned from the board of directors and the Remuneration Committee of Immunocore Holdings plc, with his departure effective immediately. His resignation was not due to any disagreements with the company or its management. On the same day, Tina St. Leger announced her resignation as Chief Human Resources Officer, effective May 26, 2026, to pursue another opportunity. Her decision was also not due to any conflicts with the company. Immunocore has initiated a search for her successor.
The most recent analyst rating on (IMCR) stock is a Buy with a $100.00 price target. To see the full list of analyst forecasts on Immunocore Holdings stock, see the IMCR Stock Forecast page.
Spark’s Take on IMCR Stock
According to Spark, TipRanks’ AI Analyst, IMCR is a Neutral.
The overall stock score is driven by strong earnings call results and positive technical indicators, indicating growth potential and market confidence. However, challenges in profitability and valuation concerns due to negative earnings and lack of dividends weigh down the score. The financial performance shows growth but also highlights areas of concern, such as cash flow and profitability.
To see Spark’s full report on IMCR stock, click here.
More about Immunocore Holdings
Average Trading Volume: 318,200
Technical Sentiment Signal: Buy
Current Market Cap: $2.03B
For a thorough assessment of IMCR stock, go to TipRanks’ Stock Analysis page.